Abstract
Introduction and hypothesis
Pessary treatment for pelvic organ prolapse (POP) is effective and safe, but long-term continuation is low. Pain and vaginal discharge may play a role. This study was aimed at evaluating vaginal discharge and pain during pessary cleaning in an outpatient setting and in continuous pessary use.
Methods
Women with POP who attended the outpatient clinic for pessary cleaning between January and October 2021 were included. Primary outcome was pain during removal and reinsertion of the pessary, measured by an 11-point numeric rating scale (NRS). Secondary outcome was vaginal discharge, measured by the NRS and Patient Global Impression of Change scale (PGI-C). Multiple linear regression analysis was used to identify associated variables for pain and discharge.
Results
A total of 150 women were included. Mean NRS during pessary removal was 4.3 (± 2.7), with 25% of women scoring a 7 or higher. Mean NRS during reinsertion was 1.8 (± 2.0). A smaller genital hiatus and presence of vaginal atrophy or vulvar skin disease were associated with pain during pessary removal. Mean NRS for vaginal discharge was 2.5 (± 2.3). Twenty-five percent of women reported that their vaginal discharge was “(very) much worse” than before they used a pessary. Presence of vaginal erosions was associated with vaginal discharge in this study population.
Conclusions
Removing a pessary in an outpatient setting is a painful procedure for many women who use a pessary continuously. Moreover, 25% of these women experience an increase in vaginal discharge while using a pessary. Future research should focus on reducing these disadvantages.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author, Kruyt LM, upon request.
References
Åkervall S, Al-Mukhtar Othman J, Molin M, Gyhagen M. Symptomatic pelvic organ prolapse in middle-aged women: a national matched cohort study on the influence of childbirth. Am J Obstet Gynecol. 2020;222(4):356.e1–14.
Islam RM, Oldroyd J, Rana J, Romero L, Karim MN. Prevalence of symptomatic pelvic floor disorders in community-dwelling women in low and middle-income countries: a systematic review and meta-analysis. Int Urogynecol J. 2019;30:2001–11.
Slieker-ten Hove MCP, Pool-Goudzwaard AL, Eijkemans MJC, Steegers-Theunissen RPM, Burger CW, Vierhout ME. Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol. 2009;200(2):184.e1–7.
Sansone S, Sze C, Eidelberg A, et al. Role of pessaries in the treatment of pelvic organ prolapse: a systematic review and meta-analysis. Obstet Gynecol. 2022;140(4):613–22.
Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–6.
Cheung RYK, Lee JHS, Lee LL, Chung TKH, Chan SSC. Vaginal pessary in women with symptomatic pelvic organ prolapse. Obstet Gynecol. 2016;128(1):73–80.
Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(2):345–50.
Deng M, Ding J, Ai F, Zhu L. Clinical use of ring with support pessary for advanced pelvic organ prolapse and predictors of its short-term successful use. Menopause. 2017;24(8):954–8.
Ding J, Chen C, Song XC, Zhang L, Deng M, Zhu L. Changes in prolapse and urinary symptoms after successful fitting of a ring pessary with support in women with advanced pelvic organ prolapse: a prospective study. Female Urol. 2016;87:70–5.
Coelho SCA, Giraldo PC, Benedito de Castro E, Brito LGO, Juliato CRT. Risk factors for dislodgment of vaginal pessaries in women with pelvic organ prolapse: a cohort study. Female Pelvic Med Reconstr Surg. 2021;27(1):247–251.
Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(4):1025–9.
Deng M, Ding J, Ai F, Zhu L. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse. Menopause. 2017;24(11):1277–81.
Bai SW, Yoon BS, Kwon JY, Shin JS, Kim SK, Park KH. Survey of the characteristics and satisfaction degree of the patients using a pessary. Int Urogynecol J. 2005;16(3):182–6.
Thys S, Hakvoort R, Milani A, Roovers JP, Vollebregt A. Can we predict continued pessary use as primary treatment in women with symptomatic pelvic organ prolapse (POP)? A prospective cohort study. Int Urogynecol J. 2021;32(8):2159–67.
Broens-Oostveen M, Mom R, Lagro-Janssen A. Genital prolapse; treatment and course in four general practices. Ned Tijdschr Geneeskd. 2004;148(29):1444–8.
Sarma S, Ying T, Moore KH. Long-term vaginal ring pessary use: discontinuation rates and adverse events. BJOG. 2009;116(13):1715–21.
de Albuquerque Coelho SC, de Castro EB, Juliato CRT. Female pelvic organ prolapse using pessaries: systematic review. Int Urogynecol J. 2016;27(12):1797–803.
de Albuquerque Coelho SC, Brito LGO, de Araujo CC, Juliato CRT. Factors associated with unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: systematic review and metanalysis. Neurourol Urodyn. 2020;39(7):1912–21.
Abdulaziz M, Stothers L, Lazare D, Macnab A. An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse. J Can Urol Assoc. 2015;9(6):E400–6.
Kakkar A, Reuveni-Salzman A, Bentaleb J, Belzile E, Merovitz L, Larouche M. Adverse events associated with pessary use over one year among women attending a pessary care clinic. Int Urogynecol J. 2023;34(8):1765–70. https://doi.org/10.1007/s00192-023-05462-z.
Collins S, Beigi R, Mellen C, O’Sullivan D, Tulikangas P. The effect of pessaries on the vaginal microenvironment. Am J Obstet Gynecol. 2015;212(1):60.1–6.
De Albuquerque Coelho SC, Giraldo PC, Florentino JO, de Castro EB, Brito LGO, Juliato CRT. Can the pessary use modify the vaginal microbiological flora? A cross-sectional study. Rev Bras Ginecol Obstet. 2017;39(4):169–74.
Alnaif B, Drutz HP. Bacterial vaginosis increases in pessary users. Int Urogynecol J. 2000;11(4):219–23.
Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10(4):390–2.
Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg Med 2018;36:707–14.
Bakker R, Peng K, Chelmow D. Speculum lubrication and patient comfort: a meta-analysis of randomized controlled trials. J Low Genit Tract Dis. 2017;21(1):67–72.
Law HY, Ng DYT, Chung CD. Use of music in reducing pain during outpatient hysteroscopy: prospective randomized trial. J Obstet Gynaecol Res. 2021;47(3):904–12.
Deo N, Khan KS, Mak J, et al. Virtual reality for acute pain in outpatient hysteroscopy: a randomised controlled trial. BJOG. 2021;128(1):87–95.
Helder-Woolderink J, de Bock G, Hollema H, van Oven M, Mourits M. Pain evaluation during gynaecological surveillance in women with Lynch syndrome. Fam Cancer. 2017;16(2):205–10.
Abbas AM, Samy A, El-NaserAbd El-Gaber Ali A, et al. Medications for pain relief in outpatient endometrial sampling or biopsy: a systematic review and network meta-analysis. Fertil Steril. 2019;112(1):140–8.e12.
Chien CW, Lo TS, Tseng LH, Lin YH, Hsieh WC, Lee SJ. Long-term outcomes of self-management Gellhorn pessary for symptomatic pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2020;26(11):e47–53.
Ziv E, Erlich T. Novel, disposable, self-inserted, vaginal device for the non-surgical management of pelvic organ prolapse: efficacy, safety, and quality of life. BMC Womens Health. 2022;22(1):459. https://doi.org/10.1186/s12905-022-02057-6.
Miceli A, Fernández-Sánchez M, Dueñas-Díez JL. How often should ring pessaries be removed or changed in women with advanced POP? A prospective observational study. Int Urogynecol J. 2021;32(6):1471–8.
Propst K, Mellen C, O’Sullivan DM, Tulikangas PK. Timing of office-based pessary care: a randomized controlled trial. Obstet Gynecol. 2020;135(1):100–5.
Manchana T. Ring pessary for all pelvic organ prolapse. Arch Gynecol Obstet. 2011;284(2):391–5.
Yimphong T, Temtanakitpaisan T, Buppasiri P, Chongsomchai C, Kanchaiyaphum S. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse. Int Urogynecol J. 2018;29(8):1123–8.
Devi AS, Anuradha J. The effect of pessaries on vaginal micro environment. IAIM. 2017;4(7):18–22.
Yoshimura K, Morotomi N, Fukuda K, Hachisuga T, Taniguchi H. Effects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora. Int Urogynecol J. 2016;27(2):219–27.
Ramaseshan A, Mellen C, O’Sullivan D, Nold C, Tulikangas P. Host inflammatory response in women with vaginal epithelial abnormalities after pessary use. Int Urogynecol J. 2022;33(8):2151–7.
Meriwether KV, Rogers RG, Craig E, Peterson SD, Gutman RE, Iglesia CB. The effect of hydroxyquinoline-based gel on pessary-associated bacterial vaginosis: a multicenter randomized controlled trial. Am J Obstet Gynecol. 2015;213(5):729.e1–e9.
Ai F, Wang Y, Wang J, Zhou L, Wang S. Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis. Climacterium. 2022;25(6):533–42.
Taithongchai A, Johnson EE, Ismail SI, Barron-Millar E, Kernohan A, Thakar R. Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women. Cochrane Database Syst Rev. 2023;7(7):CD014592. https://doi.org/10.1002/14651858.CD014592.pub2
Moore KH, Lammers K, Allen W, Parkin K, te West N. Does monthly self-management of vaginal ring pessaries reduce the rate of adverse events? A clinical audit. Eur J Obstet Gynecol Reprod Biol X. 2022;16:100164.
Yoshimura K, Morotomi N, Fukuda K, Kubo T, Taniguchi H. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse. J Obstet Gynaecol Res. 2020;46(6):931–8.
Author information
Authors and Affiliations
Contributions
Lara M. Kruyt: protocol development, data collection, data analysis, manuscript writing; J. Marinus van der Ploeg: protocol development, data collection, data analysis, manuscript writing; Karin Lammers: data collection, manuscript editing; Britt A. van Etten-Debruijn: data collection, manuscript editing; Anuschka S. Niemeijer: statistical analysis, manuscript editing; Robert A. Hakvoort: protocol development, data collection, data analysis, manuscript writing.
Corresponding author
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kruyt, L.M., van der Ploeg, J.M., Lammers, K. et al. Pessaries for pelvic organ prolapse: evaluation of vaginal discharge and pain during pessary cleaning in an outpatient setting. Int Urogynecol J 35, 333–339 (2024). https://doi.org/10.1007/s00192-023-05648-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-023-05648-5